Emerging regulatory conflicts between the Inflation Reduction Act (IRA) and the 340B program may soon force policymakers to enact major [...] …
Category: Regulatory
French pharmaceutical giant Sanofi late yesterday announced it would pause the implementation of its contested 340B rebate plan and become [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA Threatens to Remove Sanofi from 340B Program Over ‘Unapproved’ 340B Rebate Proposal
The federal department that oversees the 340B program told Sanofi late Friday afternoon that it must cease implementation of its [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The West Virginia Board of Pharmacy is beginning to act on its growing backlog of alleged violations to the state’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) is urging a federal court to dismiss two health systems’ lawsuits alleging the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital group is urging the Health Resources and Services Administration (HRSA) to intervene immediately against Sanofi’s proposed 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal government has agreed to temporarily delay any enforcement action against five health systems for their refusal to comply [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Sanofi has intensified its legal battle seeking the release of extensive 340B contract pharmacy records after announcing plans [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Bristol-Myers Squibb (BMS) sued the federal government late Tuesday to establish a 340B rebate model, joining at least [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Provider groups have strongly denounced Sanofi’s new 340B rebate model for hospitals and health centers as a costly and harmful [...] …
